BMI is an important determinant of VWF and FVIII levels and bleeding phenotype in patients with von Willebrand disease

Ferdows Atiq, Karin Fijnvandraat, Karin P. M. van Galen, Britta A. P. Laros-van Gorkom, Karina Meijer, Joke de Meris, Michiel Coppens, Eveline P. Mauser-Bunschoten, Marjon H. Cnossen, Johanna G. van der Bom, Jeroen Eikenboom, Frank W. G. Leebeek, WiN study group

Research output: Contribution to journalLetterAcademicpeer-review

Original languageEnglish
Pages (from-to)E201-E205
JournalAmerican Journal of Hematology
Volume94
Issue number8
DOIs
Publication statusPublished - 1 Aug 2019

Cite this

Atiq, F., Fijnvandraat, K., van Galen, K. P. M., Laros-van Gorkom, B. A. P., Meijer, K., de Meris, J., ... WiN study group (2019). BMI is an important determinant of VWF and FVIII levels and bleeding phenotype in patients with von Willebrand disease. American Journal of Hematology, 94(8), E201-E205. https://doi.org/10.1002/ajh.25499